Bank of New York Mellon’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $95.8M | Sell |
1,113,025
-101,312
| -8% | -$8.88M | 0.02% | 693 |
|
|
2026
Q1 | $110M | Sell |
1,214,337
-29,481
| -2% | -$2.71M | 0.02% | 594 |
|
|
2025
Q4 | $112M | Sell |
1,243,818
-153,557
| -11% | -$14.6M | 0.02% | 586 |
|
|
2025
Q3 | $138M | Sell |
1,397,375
-32,290
| -2% | -$3.2M | 0.02% | 502 |
|
|
2025
Q2 | $130M | Sell |
1,429,665
-50,692
| -3% | -$4.9M | 0.02% | 508 |
|
|
2025
Q1 | $168M | Sell |
1,480,357
-83,548
| -5% | -$8.94M | 0.03% | 402 |
|
|
2024
Q4 | $165M | Sell |
1,563,905
-2,381
| -0.2% | -$255K | 0.03% | 429 |
|
|
2024
Q3 | $169M | Sell |
1,566,286
-58,527
| -4% | -$6.39M | 0.03% | 431 |
|
|
2024
Q2 | $176M | Sell |
1,624,813
-156,476
| -9% | -$18.4M | 0.03% | 412 |
|
|
2024
Q1 | $235M | Sell |
1,781,289
-63,244
| -3% | -$7.9M | 0.05% | 336 |
|
|
2023
Q4 | $224M | Sell |
1,844,533
-29,766
| -2% | -$3.32M | 0.05% | 348 |
|
|
2023
Q3 | $210M | Sell |
1,874,299
-7,660
| -0.4% | -$973K | 0.05% | 345 |
|
|
2023
Q2 | $274M | Sell |
1,881,959
-44,992
| -2% | -$6.11M | 0.06% | 300 |
|
|
2023
Q1 | $249M | Sell |
1,926,951
-32,216
| -2% | -$4.04M | 0.05% | 317 |
|
|
2022
Q4 | $250M | Sell |
1,959,167
-38,818
| -2% | -$4.5M | 0.06% | 302 |
|
|
2022
Q3 | $209M | Sell |
1,997,985
-42,254
| -2% | -$4.64M | 0.05% | 341 |
|
|
2022
Q2 | $214M | Buy |
2,040,239
+46,554
| +2% | +$5.52M | 0.05% | 339 |
|
|
2022
Q1 | $255M | Sell |
1,993,685
-812,477
| -29% | -$97.9M | 0.05% | 342 |
|
|
2021
Q4 | $346M | Sell |
2,806,162
-496,738
| -15% | -$65M | 0.06% | 275 |
|
|
2021
Q3 | $469M | Buy |
3,302,900
+218,540
| +7% | +$32.1M | 0.09% | 191 |
|
|
2021
Q2 | $482M | Sell |
3,084,360
-16,988
| -0.5% | -$2.75M | 0.09% | 194 |
|
|
2021
Q1 | $482M | Buy |
3,101,348
+1,017,219
| +49% | +$158M | 0.1% | 182 |
|
|
2020
Q4 | $312M | Buy |
2,084,129
+42,853
| +2% | +$6.05M | 0.07% | 249 |
|
|
2020
Q3 | $270M | Buy |
2,041,276
+48,224
| +2% | +$6.3M | 0.07% | 247 |
|
|
2020
Q2 | $231M | Buy |
1,993,052
+49,252
| +3% | +$5.68M | 0.06% | 268 |
|
|
2020
Q1 | $191M | Sell |
1,943,800
-62,744
| -3% | -$8.22M | 0.06% | 266 |
|
|
2019
Q4 | $292M | Sell |
2,006,544
-17,162
| -0.8% | -$2.37M | 0.08% | 247 |
|
|
2019
Q3 | $270M | Sell |
2,023,706
-246,758
| -11% | -$31.9M | 0.07% | 254 |
|
|
2019
Q2 | $260M | Sell |
2,270,464
-62,351
| -3% | -$7.3M | 0.07% | 263 |
|
|
2019
Q1 | $289M | Sell |
2,332,815
-81,747
| -3% | -$9.29M | 0.08% | 226 |
|
|
2018
Q4 | $243M | Sell |
2,414,562
-94,830
| -4% | -$10.7M | 0.08% | 241 |
|
|
2018
Q3 | $320M | Buy |
2,509,392
+32,508
| +1% | +$3.87M | 0.08% | 232 |
|
|
2018
Q2 | $268M | Sell |
2,476,884
-29,870
| -1% | -$3.25M | 0.07% | 267 |
|
|
2018
Q1 | $265M | Sell |
2,506,754
-209,008
| -8% | -$24.3M | 0.07% | 277 |
|
|
2017
Q4 | $318M | Sell |
2,715,762
-126,733
| -4% | -$14.3M | 0.08% | 233 |
|
|
2017
Q3 | $323M | Buy |
2,842,495
+557,335
| +24% | +$64.3M | 0.09% | 232 |
|
|
2017
Q2 | $285M | Sell |
2,285,160
-79,117
| -3% | -$9.38M | 0.08% | 258 |
|
|
2017
Q1 | $280M | Sell |
2,364,277
-313,289
| -12% | -$35.5M | 0.08% | 266 |
|
|
2016
Q4 | $268M | Buy |
2,677,566
+20,850
| +0.8% | +$2.23M | 0.08% | 269 |
|
|
2016
Q3 | $335M | Buy |
2,656,716
+362,109
| +16% | +$44.7M | 0.1% | 212 |
|
|
2016
Q2 | $268M | Buy |
2,294,607
+512,777
| +29% | +$58M | 0.08% | 258 |
|
|
2016
Q1 | $184M | Buy |
1,781,830
+5,534
| +0.3% | +$535K | 0.06% | 338 |
|
|
2015
Q4 | $177M | Sell |
1,776,296
-66,635
| -4% | -$6.52M | 0.05% | 353 |
|
|
2015
Q3 | $168M | Sell |
1,842,931
-17,088
| -0.9% | -$1.71M | 0.05% | 370 |
|
|
2015
Q2 | $197M | Sell |
1,860,019
-54,795
| -3% | -$6.06M | 0.05% | 363 |
|
|
2015
Q1 | $218M | Sell |
1,914,814
-30,286
| -2% | -$3.46M | 0.06% | 358 |
|
|
2014
Q4 | $214M | Buy |
1,945,100
+2,945
| +0.2% | +$310K | 0.06% | 360 |
|
|
2014
Q3 | $190M | Buy |
1,942,155
+13,612
| +0.7% | +$1.34M | 0.05% | 368 |
|
|
2014
Q2 | $194M | Sell |
1,928,543
-15,048
| -0.8% | -$1.47M | 0.05% | 369 |
|
|
2014
Q1 | $178M | Sell |
1,943,591
-36,548
| -2% | -$3.37M | 0.05% | 380 |
|
|
2013
Q4 | $179M | Sell |
1,980,139
-140,661
| -7% | -$12.2M | 0.05% | 375 |
|
|
2013
Q3 | $169M | Buy |
2,120,800
+53,969
| +3% | +$4.25M | 0.05% | 382 |
|
|
2013
Q2 | $150M | Buy |
+2,066,831
| New | +$155M | 0.05% | 395 |
|
Other funds holding ZBH
EIC
Bank of New York Mellon's ZBH Position: Q2 2026 in Review
Bank of New York Mellon reduced its Zimmer Biomet (ZBH) stake by 8.3% in Q2 2026, selling an estimated $8.88M and leaving 1,113,025 shares worth $95.8M. The position accounts for 0.02% of the portfolio, ranked #693.
Bank of New York Mellon first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $482M in Q1 2021. 631 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Bank of New York Mellon held 1,113,025 shares of Zimmer Biomet worth $95.8M as of Q2 2026.
- Bank of New York Mellon sold 101,312 Zimmer Biomet shares in Q2 2026, an estimated $8.88M.
- Zimmer Biomet made up 0.02% of Bank of New York Mellon's portfolio in Q2 2026, its #693 holding.
- Bank of New York Mellon first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Zimmer Biomet position peaked at $482M in Q1 2021.
- 631 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.